# Beijing Taichuang Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-taichuang-biotechnology-co

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.tidetronbio.com
- Latest round: Series A (Mar 14, 2022)
- Investors on record: 3

## About

Founded in 2021 and based in Guangzhou, China, Beijing Taichuang Biotechnology Co., Ltd. is a biotech company that focuses on the development of biosynthetic technology. Dr. Zhang Zhiqian, the founder of the company, graduated from Sun Yat-Sen University. As of 2022, the company has more than 80 employees, including about 30 R&D personnel.

The company focuses on the development of microbial cells in the beauty, food and beverage, household cleaning and other fields. Its main products include small molecule peptides and erythritol. The company's Tidetron Altra platform strain library enables directed evolution of microbial cells through the design and construction of synthetic pathways.

In 2021, the company's operating income reached nearly CNY 100 million.

## Funding rounds

- Series A, Mar 14, 2022 — Legend Capital, IDG Capital
- Series A, Sep 26, 2021 — IDG Capital
- Angel, Mar 24, 2021 — Unity Ventures

## Investors

- Unity Ventures (https://capitalatlas.ai/funds/unity-ventures) — Angel
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Legend Capital — Series A